Kim KH - Search Results

1

PD-1 blockade-unresponsive human tumor-infiltrating CD8⁺ T cells are marked by loss of CD28 expression and rescued by IL-15.

Kim KH, Kim HK, Kim HD, Kim CG, Lee H, Han JW, Choi SJ, Jeong S, Jeon M, Kim H, Koh J, Ku BM, Park SH, Ahn MJ, Shin EC. Kim KH, et al. Among authors: kim h, kim hk, kim cg, kim hd. Cell Mol Immunol. 2021 Feb;18(2):385-397. doi: 10.1038/s41423-020-0427-6. Epub 2020 Apr 24. Cell Mol Immunol. 2021. PMID: 32332901 Free PMC article.

2

Innate-like Cytotoxic Function of Bystander-Activated CD8⁺ T Cells Is Associated with Liver Injury in Acute Hepatitis A.

Kim J, Chang DY, Lee HW, Lee H, Kim JH, Sung PS, Kim KH, Hong SH, Kang W, Lee J, Shin SY, Yu HT, You S, Choi YS, Oh I, Lee DH, Lee DH, Jung MK, Suh KS, Hwang S, Kim W, Park SH, Kim HJ, Shin EC. Kim J, et al. Among authors: kim w, kim hj, kim kh, kim jh. Immunity. 2018 Jan 16;48(1):161-173.e5. doi: 10.1016/j.immuni.2017.11.025. Epub 2018 Jan 2. Immunity. 2018. PMID: 29305140 Free article.

3

Association Between Expression Level of PD1 by Tumor-Infiltrating CD8⁺ T Cells and Features of Hepatocellular Carcinoma.

Kim HD, Song GW, Park S, Jung MK, Kim MH, Kang HJ, Yoo C, Yi K, Kim KH, Eo S, Moon DB, Hong SM, Ju YS, Shin EC, Hwang S, Park SH. Kim HD, et al. Among authors: kim mh, kim kh. Gastroenterology. 2018 Dec;155(6):1936-1950.e17. doi: 10.1053/j.gastro.2018.08.030. Epub 2018 Aug 24. Gastroenterology. 2018. PMID: 30145359

4

Senescent T Cells Predict the Development of Hyperglycemia in Humans.

Lee YH, Kim SR, Han DH, Yu HT, Han YD, Kim JH, Kim SH, Lee CJ, Min BH, Kim DH, Kim KH, Cho JW, Lee WW, Shin EC, Park S. Lee YH, et al. Among authors: kim sr, kim dh, kim sh, kim kh, kim jh. Diabetes. 2019 Jan;68(1):156-162. doi: 10.2337/db17-1218. Epub 2018 Nov 2. Diabetes. 2019. PMID: 30389747

5

The First-week Proliferative Response of Peripheral Blood PD-1⁺CD8⁺ T Cells Predicts the Response to Anti-PD-1 Therapy in Solid Tumors.

Kim KH, Cho J, Ku BM, Koh J, Sun JM, Lee SH, Ahn JS, Cheon J, Min YJ, Park SH, Park K, Ahn MJ, Shin EC. Kim KH, et al. Clin Cancer Res. 2019 Apr 1;25(7):2144-2154. doi: 10.1158/1078-0432.CCR-18-1449. Epub 2019 Jan 15. Clin Cancer Res. 2019. PMID: 30647082

6

Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation.

Kim CG, Lee HW, Choi HJ, Lee JI, Lee HW, Kim SU, Park JY, Kim DY, Ahn SH, Han KH, Kim HS, Kim KH, Choi SJ, Kim Y, Lee KS, Kim GM, Kim MD, Won JY, Lee DY, Kim BK. Kim CG, et al. Among authors: kim su, kim dy, kim gm, kim md, kim bk, kim hs, kim y, kim kh. Cancer Med. 2019 Sep;8(11):5023-5032. doi: 10.1002/cam4.2417. Epub 2019 Jul 10. Cancer Med. 2019. PMID: 31290618 Free PMC article.

7

4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8⁺ T Cells in Hepatocellular Carcinoma.

Kim HD, Park S, Jeong S, Lee YJ, Lee H, Kim CG, Kim KH, Hong SM, Lee JY, Kim S, Kim HK, Min BS, Chang JH, Ju YS, Shin EC, Song GW, Hwang S, Park SH. Kim HD, et al. Among authors: kim hk, kim cg, kim s, kim kh. Hepatology. 2020 Mar;71(3):955-971. doi: 10.1002/hep.30881. Epub 2019 Oct 18. Hepatology. 2020. PMID: 31353502 Free PMC article.

8

Functions of human liver CD69⁺CD103^-CD8⁺ T cells depend on HIF-2α activity in healthy and pathologic livers.

Kim JH, Han JW, Choi YJ, Rha MS, Koh JY, Kim KH, Kim CG, Lee YJ, Kim AR, Park J, Kim HK, Min BS, Seo SI, Kang M, Park HJ, Han DH, Kim SI, Kim MS, Lee JG, Lee DH, Kim W, Park JY, Park SH, Joo DJ, Shin EC. Kim JH, et al. Among authors: kim ar, kim w, kim hk, kim cg, kim si, kim ms, kim kh. J Hepatol. 2020 Jun;72(6):1170-1181. doi: 10.1016/j.jhep.2020.01.010. Epub 2020 Jan 24. J Hepatol. 2020. PMID: 31987989

9

Kim KH, Hur JY, Cho J, Ku BM, Koh J, Koh JY, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ, Shin EC. Kim KH, et al. Oncoimmunology. 2020 Feb 2;9(1):1722023. doi: 10.1080/2162402X.2020.1722023. eCollection 2020. Oncoimmunology. 2020. PMID: 32076579 Free PMC article.

10

Tumor immune microenvironment in cancer patients with leukocytosis.

Kim KH, Sim NS, Chang JS, Kim YB. Kim KH, et al. Among authors: kim yb. Cancer Immunol Immunother. 2020 Jul;69(7):1265-1277. doi: 10.1007/s00262-020-02545-4. Epub 2020 Mar 13. Cancer Immunol Immunother. 2020. PMID: 32170377 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,473 results

Search Page

Filters